Osaka, Japan

Noriyoshi Yamamoto


Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Shijonawate, JP (1999)
  • Osaka, JP (2006 - 2011)
  • Ikoma, JP (2014 - 2015)

Company Filing History:


Years Active: 1999-2015

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Noriyoshi Yamamoto: Innovator in Pharmaceutical Chemistry

Introduction

Noriyoshi Yamamoto is a distinguished inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His innovative work focuses on the development of novel compounds and manufacturing methods that have potential applications in medicine.

Latest Patents

Yamamoto's latest patents include a method for manufacturing a 3-hydroxy-6H-benzo [C] chromene-6-one derivative. This method involves causing a compound or a salt thereof, expressed with a specific formula, to react in the presence of carbonate and copper salt or in the presence of hydroxide salt, carbonate, and copper salt. This innovative approach showcases his expertise in chemical synthesis and compound development.

Career Highlights

Throughout his career, Noriyoshi Yamamoto has been associated with Santen Pharmaceutical Co., Ltd., where he has contributed to various research and development projects. His work has not only advanced the company's objectives but has also enriched the pharmaceutical industry with new methodologies and compounds.

Collaborations

Yamamoto has collaborated with notable colleagues, including Masakazu Ban and Hiroshi Suhara. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Noriyoshi Yamamoto's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of new therapeutic compounds, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…